State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now
- PMID: 27232110
- PMCID: PMC5124531
- DOI: 10.3322/caac.21352
State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now
Abstract
Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3% annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma-associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors-health care, government, education, business, advocacy, and community-to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States. CA Cancer J Clin 2016;66:460-480. © 2016 American Cancer Society.
Keywords: US Food and Drug Administration; US Preventive Services Task Force; indoor tanning; legislation as topic; melanoma/epidemiology; melanoma/prevention and control; public health; sunbathing; suntan; ultraviolet rays/adverse effects.
© 2016 American Cancer Society, Inc.
Figures
Similar articles
-
Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Feb. Report No.: 11-05152-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Feb. Report No.: 11-05152-EF-1. PMID: 21542545 Free Books & Documents. Review.
-
Knowledge about Ultraviolet Radiation Hazards and Tanning Behavior of Cosmetology and Medical Students.Acta Dermatovenerol Croat. 2016 Apr;24(1):73-7. Acta Dermatovenerol Croat. 2016. PMID: 27149135
-
The potential impact of reducing indoor tanning on melanoma prevention and treatment costs in the United States: An economic analysis.J Am Acad Dermatol. 2017 Feb;76(2):226-233. doi: 10.1016/j.jaad.2016.09.029. Epub 2016 Dec 6. J Am Acad Dermatol. 2017. PMID: 27939556 Free PMC article.
-
Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force.Ann Intern Med. 2011 Feb 1;154(3):190-201. doi: 10.7326/0003-4819-154-3-201102010-00009. Ann Intern Med. 2011. PMID: 21282699 Review.
-
Teens and indoor tanning: a cancer prevention opportunity for pediatricians.Pediatrics. 2013 Apr;131(4):772-85. doi: 10.1542/peds.2012-2404. Epub 2013 Mar 18. Pediatrics. 2013. PMID: 23509165 Free PMC article. Review.
Cited by 55 articles
-
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.JAMA Dermatol. 2022 Apr 1;158(4):426-431. doi: 10.1001/jamadermatol.2022.0139. JAMA Dermatol. 2022. PMID: 35293957
-
The Anticancer Potential of Doxycycline and Minocycline-A Comparative Study on Amelanotic Melanoma Cell Lines.Int J Mol Sci. 2022 Jan 13;23(2):831. doi: 10.3390/ijms23020831. Int J Mol Sci. 2022. PMID: 35055021 Free PMC article.
-
Low-Dose Albendazole Inhibits Epithelial-Mesenchymal Transition of Melanoma Cells by Enhancing Phosphorylated GSK-3β/Tyr216 Accumulation.J Oncol. 2021 Dec 20;2021:4475192. doi: 10.1155/2021/4475192. eCollection 2021. J Oncol. 2021. PMID: 34966427 Free PMC article.
-
Low Blue Dose Photodynamic Therapy with Porphyrin-Iron Oxide Nanoparticles Complexes: In Vitro Study on Human Melanoma Cells.Pharmaceutics. 2021 Dec 10;13(12):2130. doi: 10.3390/pharmaceutics13122130. Pharmaceutics. 2021. PMID: 34959411 Free PMC article.
-
Targeted therapy strategies for melanoma brain metastasis.Neurooncol Adv. 2021 Nov 27;3(Suppl 5):v75-v85. doi: 10.1093/noajnl/vdab131. eCollection 2021 Nov. Neurooncol Adv. 2021. PMID: 34859235 Free PMC article.
Publication types
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous